Suchergebnisse - "Scribano, Maria Lia"

PubPharm (58)

1

Crohn's disease after surgery : Changes in post-operative management strategies over time and their impact on long-term re-operation rate-A retrospective multicentre real-world study

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Aratari, A. | Scribano, M. | Pugliese, D. | +7

2

Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis : A Prospective Multicenter Italian Study

enthalten in: Digestive diseases and sciences | 2024

von Carvalhas Gabrielli, A. | Ferretti, F. | Monico, C. | +15

3

SARS-CoV-2 infection in patients with inflammatory bowel disease : comparison between the first and second pandemic waves

enthalten in: BMC gastroenterology | 2023

von Bezzio, C. | Vernero, M. | Costa, S. | +72

4

Use of biologics for the management of Crohn's disease : IG-IBD clinical guidelines based on the GRADE methodology

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Macaluso, F. | Papi, C. | Orlando, A. | +55

CommentIn: Dig Liver Dis. 2023 Jul;55(7):989. - PMID 37193630

5

Editorial : shared decision-making intervention in patients with Crohn's disease-a personalised, patient-centred approach

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Scribano, M.

CommentOn: Aliment Pharmacol Ther. 2023 Jan;57(2):205-214. - PMID 36377259

6

Personalize, participate, predict, and prevent : 4Ps in inflammatory bowel disease

enthalten in: Frontiers in medicine | 2023

von Lenti, M. | Scribano, M. | Biancone, L. | +19

7

Editorial : shared decision‐making intervention in patients with Crohnʼs disease—a personalised, patient‐centred approach

enthalten in: Alimentary Pharmacology & Therapeutics | 2023

von Scribano, M.

8

Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease : the IG-IBD LIVE study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Pugliese, D. | Privitera, G. | Crispino, F. | +58

CommentIn: Aliment Pharmacol Ther. 2022 Aug;56(4):731-732. - PMID 35879894

9

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis : IG-IBD clinical guidelines based on the GRADE methodology

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2022

von Macaluso, F. | Orlando, A. | Papi, C. | +55

10

Effectiveness of adalimumab for ulcerative colitis : A multicentre, retrospective study of clinical practice in Italy

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2022

von Vitello, A. | Grova, M. | Pugliese, D. | +25

1
2
3
4
5
6
Nächster »
[6]